In a recent work, Rosenkranz et al. (2020) observed no protection in mice lacking TRPV4 in various pathological models, such as multiple sclerosis, experimental autoimmune encephalomyelitis and transient MCAO. Here, TRPV4 is linked to experimental autoimmune encephalomyelitis.